McKesson Ventures

McKesson Ventures, established in 2014, is the venture capital arm of McKesson Corporation, a leading healthcare services and information technology company. Based in San Francisco, California, McKesson Ventures invests in early and growth-stage healthcare technology companies, focusing on digital health and technology-enabled services that serve the needs of pharmaceutical companies, pharmacies, healthcare providers, and patients. The firm seeks minority investments, typically ranging from $20 million to $25 million, to support entrepreneurs creating efficient healthcare delivery systems for key stakeholders across the healthcare economy.

Jennifer Carter

Partner and Vice President Venture Operations

Priyanka Kanal

Associate

Dave Schulte

Managing Director

Michelle Snyder

Partner

Carrie Williams

Partner

Brian Zhu

Senior Associate

109 past transactions

Lumata Health

Series B in 2025
Lumata Health is a technology-driven healthcare startup dedicated to preventing blindness caused by chronic eye conditions. Founded in 2017 by Stephen R. Fransen, an experienced ophthalmologist and retina specialist, the company manages thousands of patients at risk of vision loss in the United States. Lumata Health employs a human-led care coordination and management platform that is typically free for patients. By collaborating with physicians, payers, and health systems, Lumata Health provides comprehensive care management services delivered by eye care experts, enhanced by advanced technology and data science. The company focuses on improving clinical outcomes, patient satisfaction, and clinic staff efficiency through proactive patient assistance and care coordination for conditions such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. By identifying and addressing barriers to treatment adherence, Lumata Health aims to support patients in their recovery from chronic eye care challenges.

Lynx

Series A in 2025
Lynx is a fintech healthcare company that focuses on integrating financial solutions with healthcare services. Its API-connected platform facilitates healthcare payments, banking, and e-commerce, allowing businesses to offer tailored health-fintech solutions. By bridging the gap between health and finances, Lynx aims to enhance affordability, drive health engagement, and improve financial security for consumers. The company's technology infrastructure empowers partners to provide a seamless consumer experience, ultimately helping healthcare professionals improve patient outcomes and reduce administrative inefficiencies.

PRISM Vision Group

Acquisition in 2025
PRISM Vision Group is a healthcare company that specializes in comprehensive support services to eye care organizations. It specializes in advanced surgical, injection, and medical approaches for patients with all types of retinal problems.

Bluenote Health

Venture Round in 2024
Bluenote Health operates as an AI platform for life sciences.

Core Ventures Group

Acquisition in 2024
Core Ventures Group, LLC, established in 2012 and headquartered in Palo Alto, California, is a venture capital firm specializing in early-stage investments. It focuses on direct investments, particularly in seed/startup and early-stage B2B companies within the advanced information technology sector. The firm aims to be among the first investors in its portfolio companies, providing support and working closely with founders to help them succeed.

HarmonyCares

Venture Round in 2024
HarmonyCares is a provider of home health care services focused on delivering high-quality medical care directly to clients in their homes. The company offers an integrated, physician-driven model that includes primary and specialty care programs tailored for individuals with multiple chronic conditions, cognitive issues, and psychosocial complications. In addition to primary care, HarmonyCares provides ancillary services such as home health, hospice, palliative care, radiology, and laboratory testing. The rebranding from U.S. Medical Management to HarmonyCares in 2022 reflects the company's commitment to enhancing the care experience for patients, particularly the elderly, by enabling them to receive essential health services in a familiar and comfortable environment.

Atropos Health

Series B in 2024
Atropos Health, founded in 2019 and based in Palo Alto, California, specializes in developing a digital prognostogram platform that transforms health data into usable real-world evidence. The Atropos Evidence Platform integrates electronic medical record (EMR) data to generate digital evidence tailored to individual patient outcomes. It serves a diverse clientele, including healthcare organizations, life science companies, and researchers, by enabling them to derive value from previously isolated EMR data. This cloud-based platform addresses evidence gaps from bench to bedside, enhances clinical outcomes through data-driven care, and accelerates research efforts in the medical field.

Compile

Acquisition in 2024
Compile is a technology company focused on the life sciences and healthcare industries, providing data-driven insights through its Healthgraph platform. This platform utilizes a vast repository of medical claims, capturing approximately 70% of all claims from 2015 onwards, alongside a significant sample of prescription claims. By integrating this real-world data with various public sources, Compile offers pharmaceutical and medical device companies enhanced visibility into patient treatment pathways, healthcare professionals involved, and the relationships among healthcare organizations. The insights derived from Healthgraph assist clients in addressing critical questions throughout the entire commercial lifecycle, from pre-launch market research to post-launch strategies. Compile's solutions aim to organize and refine complex datasets into accessible and analytics-ready formats, facilitating informed decision-making in the healthcare sector.

Inbound Health

Series B in 2023
Inbound Health is a company that specializes in facilitating hospital-at-home and skilled nursing-at-home programs for health systems and health plans. The company leverages AI-based technology to create a safe and predictive care model within a scalable and integrated environment. This approach allows patients to receive real-time, high-quality care and oversight from the comfort of their own homes.

RxLightning

Series A in 2023
RxLightning is a digital platform that focuses on improving access to specialty medications for patients. By automating and streamlining the traditionally complex manual enrollment process, RxLightning facilitates faster initiation of therapy across various therapeutic areas, including addiction medicine, cardiology, endocrinology, and dermatology. The platform enhances communication between healthcare providers and reduces the burden of paperwork, thereby accelerating the time it takes for patients to access necessary treatments.

Glide Health

Acquisition in 2023
Glide Health is a health technology company that develops intelligent financial solutions aimed at enhancing revenue and cash flow for healthcare organizations. Utilizing proprietary AI and machine learning technology, Glide Health's platform integrates operations across healthcare entities, offering targeted guidance to improve revenue cycle management. The Glide Intelligence platform generates predictive analytics and actionable recommendations, facilitating key processes such as patient registration, prior authorization, claim submission, denial management, and collections. By providing real-time analysis of financial and clinical data, Glide Health enables healthcare providers to gain greater visibility into their financial health through advanced forecasting of metrics like revenue and accounts receivable. In addition, Glide Mobile Health, a component of the company's offerings, serves as a comprehensive mobile solution, allowing patients and healthcare professionals to access and manage medical records securely from various devices. This ensures effective collaboration in patient care and enhances the overall quality of healthcare delivery, while also reducing costs through improved integration and coordination of health information management systems.

Glide Health

Acquisition in 2023
Glide Health is a health technology company that develops intelligent financial solutions aimed at enhancing revenue and cash flow for healthcare organizations. Utilizing proprietary AI and machine learning technology, Glide Health's platform integrates operations across healthcare entities, offering targeted guidance to improve revenue cycle management. The Glide Intelligence platform generates predictive analytics and actionable recommendations, facilitating key processes such as patient registration, prior authorization, claim submission, denial management, and collections. By providing real-time analysis of financial and clinical data, Glide Health enables healthcare providers to gain greater visibility into their financial health through advanced forecasting of metrics like revenue and accounts receivable. In addition, Glide Mobile Health, a component of the company's offerings, serves as a comprehensive mobile solution, allowing patients and healthcare professionals to access and manage medical records securely from various devices. This ensures effective collaboration in patient care and enhances the overall quality of healthcare delivery, while also reducing costs through improved integration and coordination of health information management systems.

Perceiv AI

Seed Round in 2022
Perceiv AI is an innovative healthcare company focused on advancing precision medicine through the application of artificial intelligence. The company aims to enhance patient care by improving the efficiency and accuracy of subject targeting and prognosis using sophisticated machine learning algorithms. Perceiv AI addresses the complexities of clinical trials by helping pharmaceutical companies identify the most suitable populations for treatment, thereby increasing the likelihood of successful outcomes. Its AI-driven precision medicine platform integrates various types of longitudinal data—including imaging, genetic, phenotypic, and clinical variables—to create detailed profiles of individuals. This allows healthcare organizations and pharmaceutical firms to better target at-risk individuals, particularly in challenging areas like age-related diseases, including CNS/Alzheimer's disease and cardiovascular conditions.

Rx Savings Solutions

Acquisition in 2022
Rx Savings Solutions is a healthcare technology company founded by a pharmacist that focuses on reducing prescription drug costs for individuals and payers. The company operates a SaaS-based platform that analyzes medication claim information using proprietary algorithms to provide personalized recommendations for optimizing therapy and lowering costs. With over 9 million members, Rx Savings Solutions offers tools that promote transparency and engagement in the prescription process, as well as access to dedicated pharmacy experts who assist members in navigating their benefits, providers, and pharmacies. This approach empowers clients to become informed consumers of healthcare, ultimately leading to significant savings on prescription medications.

OncoHealth

Private Equity Round in 2022
OncoHealth specializes in oncology benefits management solutions aimed at alleviating the physical, mental, and financial burdens of cancer. The company offers a range of services including prior authorization, clinical decision support, physician education, and expert peer review. Additionally, OncoHealth provides consulting for oncology network evaluation and optimization, as well as performance reporting and analytics. The company also features MATIS, a clinical decision support software that enhances oncology analytics through an evidence-based approach to cancer treatment evaluation and benefits management. Founded in 2009 and headquartered in Atlanta, Georgia, with a secondary location in Plantation, Florida, OncoHealth serves health plans, employers, providers, patients, and life science researchers, leveraging technology and real-world data to navigate the complexities associated with cancer care.

CancerIQ

Series B in 2022
CancerIQ is a precision health technology company focused on empowering healthcare providers to identify and manage patients at high risk for cancer. Its platform offers a comprehensive suite of tools, including predictive analytics and screening resources, to help clinicians accurately stratify patient risk and guide them toward appropriate genetic testing, screening, or treatment options. The platform features a robust content library of evidence-based guidelines and risk models, facilitating informed decision-making. Additionally, CancerIQ provides digital tools for genetic test ordering and patient management, aimed at enhancing patient education and engagement. By streamlining these processes, the company enables healthcare providers to improve patient outcomes and reduce the overall cost of care through early cancer detection.

Koneksa

Series C in 2022
Koneksa Health Inc. is a healthcare data analytics company that specializes in designing and developing software solutions for pharmaceutical and biotech firms. The company’s flagship product, Koneksa Compare, facilitates the collection, monitoring, and analysis of patient-generated data to support clinical studies and regulatory claims. By integrating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires, Koneksa enhances the accuracy and breadth of data that researchers can analyze, thereby minimizing subjective biases in clinical endpoints. Additionally, the platform provides a dashboard that offers electronic clinical outcome assessments and reminders for study participants. Established in 2013 and headquartered in New York, Koneksa also maintains a presence in London, United Kingdom, and is recognized for its contributions to improving the efficiency of drug development through innovative data analysis.

Reimagine Care

Series A in 2022
Reimagine Care is a healthcare company focused on enhancing community-based oncology care through technology-enabled services. Founded in 2020 and headquartered in Nashville, Tennessee, the company aims to make high-quality cancer care more affordable and accessible for patients. Reimagine Care collaborates with healthcare systems and independent oncology practices to facilitate value-based care delivery. By offering a comprehensive technology platform alongside essential personnel and processes, the company enables the scalable and effective provision of patient-centric cancer care across various settings, including patients' homes. This approach supports the delivery of low-cost cancer treatment and supportive services, ultimately improving the overall patient experience.

Lightship

Series C in 2021
Lightship is a company founded in 2018 that focuses on transforming clinical trials to enhance health equity globally. By leveraging digital health innovations and remote care, it aims to make clinical research more accessible and patient-centered. Lightship provides decentralized and hybrid clinical services that improve patient experience, retention, and trial diversity. Its approach expands the pool of potential participants by moving beyond traditional research centers, effectively meeting patients in their own environments. This strategy helps to eliminate the barriers and inefficiencies associated with conventional clinical trial models, ultimately making medical research more inclusive and effective.

IVX Health

Series F in 2021
IVX Health is a prominent provider of infusion and injection therapy, catering to patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics designed to deliver biologic injections and infusions in a private, comfortable, and convenient environment, enhancing the overall patient experience. IVX Health centers, branded as Infusion Express in various cities including Kansas City, Philadelphia, Chicago, and San Francisco, offer flexible scheduling options, including evenings and weekends. Each center features private suites equipped with high-speed Wi-Fi, flat screen TVs, and comfortable recliners, allowing patients to relax during their treatments alongside guests. By focusing on patient comfort and accessibility, IVX Health aims to optimize the infusion care process, making it more effective and cost-efficient for both patients and healthcare providers.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of new treatments for rare diseases. The company has created a platform that enables the generation of regulatory-ready evidence, facilitating rare disease research and drug development. AllStripes operates a two-sided network that connects patients with rare diseases and advocacy groups to life science companies seeking new drug candidates. Through this network, patients can contribute their medical data and participate in treatment research online, while life science companies gain access to valuable data and insights to support their drug development efforts.

Evidation Health

Series E in 2021
Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

M2Gen

Private Equity Round in 2021
M2Gen, Corp. is a health informatics solutions company headquartered in Tampa, Florida, established in 2006 at the Moffitt Cancer Center. It specializes in advancing precision medicine through its integrated clinical and molecular data platform, which analyzes data to enhance patient care. M2Gen provides evidence-based solutions that help identify disease susceptibility, predict drug responses, and match patients with optimal therapies. The company operates the Total Cancer Care Protocol, a comprehensive approach that studies patients throughout their lifetime, and collaborates with leading cancer centers through the Oncology Research Information Exchange Network (ORIEN). Additionally, M2Gen offers the M2Gen Portfolio, which supports biopharmaceutical companies in discovering new targets and biomarkers, improving clinical trial design and enrollment, and facilitating long-term post-market analysis. M2Gen was formerly known as Moffitt Genetics Corporation, Inc. and rebranded in August 2017. It operates as a subsidiary of the H. Lee Moffitt Cancer Center & Research Institute.

Aspen RxHealth

Series B in 2021
Aspen RxHealth is a Tampa, Florida-based company that provides an online platform designed to connect licensed pharmacists with patients requiring enhanced medication services. Through its app-based technology, Aspen RxHealth facilitates direct patient care by matching pharmacists with patients based on various social and clinical criteria, including language and medication regimens. The platform enables health plans and providers to efficiently link their patients to a community of pharmacists who can offer specialized clinical services, ranging from comprehensive medication reviews to targeted interventions. By optimizing communication and simplifying processes, Aspen RxHealth aims to improve patient outcomes and enhance the delivery of pharmaceutical care.

Clinical Ink

Venture Round in 2020
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.

Vineti

Series C in 2020
Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

Augmedix

Private Equity Round in 2020
Augmedix, Inc. is a technology company focused on transforming medical documentation and clinical support through its innovative application. Founded in 2012 and headquartered in San Francisco, California, with additional offices in Menlo Park and Dhaka, the company provides a cloud-based platform that utilizes ambient AI to convert clinician-patient conversations into organized medical notes in real-time. This process significantly reduces the administrative burden on healthcare providers, allowing them to concentrate more on patient care. Augmedix's services are designed for a wide range of healthcare settings, from large hospitals to individual practitioners, enabling seamless integration with electronic health records. The company collaborates with various healthcare organizations to enhance clinical efficiency, operational productivity, and financial performance, charging service fees for its documentation and clinical support services.

Koneksa

Series B in 2020
Koneksa Health Inc. is a healthcare data analytics company that specializes in designing and developing software solutions for pharmaceutical and biotech firms. The company’s flagship product, Koneksa Compare, facilitates the collection, monitoring, and analysis of patient-generated data to support clinical studies and regulatory claims. By integrating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires, Koneksa enhances the accuracy and breadth of data that researchers can analyze, thereby minimizing subjective biases in clinical endpoints. Additionally, the platform provides a dashboard that offers electronic clinical outcome assessments and reminders for study participants. Established in 2013 and headquartered in New York, Koneksa also maintains a presence in London, United Kingdom, and is recognized for its contributions to improving the efficiency of drug development through innovative data analysis.

Pharmapacks

Private Equity Round in 2020
Pharmapacks is an e-commerce company based in Islandia, New York, specializing in health and beauty products. Established in 2010 as a brick-and-mortar pharmacy, the company has evolved into a comprehensive online marketplace that offers a wide range of items, including multivitamins, nutritional supplements, personal care, and pet care products. Through its proprietary technology platform, Pharmapacks provides logistics, fulfillment, marketing, and sales solutions to brands, enabling them to reach consumers directly via its website and partner platforms such as Amazon, Walmart.com, and eBay. The company also serves as a launchpad for emerging brands, granting select lesser-known products access to its extensive e-commerce infrastructure and consumer base, thereby enhancing their visibility and sales potential.

Evidation Health

Series D in 2020
Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

OncoHealth

Series C in 2020
OncoHealth specializes in oncology benefits management solutions aimed at alleviating the physical, mental, and financial burdens of cancer. The company offers a range of services including prior authorization, clinical decision support, physician education, and expert peer review. Additionally, OncoHealth provides consulting for oncology network evaluation and optimization, as well as performance reporting and analytics. The company also features MATIS, a clinical decision support software that enhances oncology analytics through an evidence-based approach to cancer treatment evaluation and benefits management. Founded in 2009 and headquartered in Atlanta, Georgia, with a secondary location in Plantation, Florida, OncoHealth serves health plans, employers, providers, patients, and life science researchers, leveraging technology and real-world data to navigate the complexities associated with cancer care.

Amwell

Series C in 2020
Amwell is a telehealth platform based in the United States that facilitates the digital delivery of healthcare services. Founded in 2006 and headquartered in Boston, the company connects providers, insurers, patients, and innovators to enhance access to affordable, high-quality care. Amwell offers a comprehensive platform designed to address a wide range of telehealth needs, including urgent, acute, and post-acute care, as well as chronic care management and healthy living. With extensive experience in the field, Amwell supports over 240 health systems, which encompass 2,000 hospitals, and collaborates with 55 health plan partners, reaching more than 150 million individuals through over 36,000 employers. The platform provides both on-demand and scheduled consultations, enabling diverse care models that range from primary and urgent care to specialized services such as telestroke and telepsychiatry.

Lightship

Series B in 2020
Lightship is a company founded in 2018 that focuses on transforming clinical trials to enhance health equity globally. By leveraging digital health innovations and remote care, it aims to make clinical research more accessible and patient-centered. Lightship provides decentralized and hybrid clinical services that improve patient experience, retention, and trial diversity. Its approach expands the pool of potential participants by moving beyond traditional research centers, effectively meeting patients in their own environments. This strategy helps to eliminate the barriers and inefficiencies associated with conventional clinical trial models, ultimately making medical research more inclusive and effective.

Matternet

Series B in 2020
Matternet is a leading developer of commercial drone delivery systems tailored for urban and suburban environments. The company offers the Matternet M2 drone alongside its proprietary software platform, enabling automated package exchange and efficient logistics operations. Matternet operates its technology directly for customers and collaborates with logistics organizations, such as UPS. In 2017, it became the first company authorized for commercial Beyond Visual Line of Sight (BVLOS) operations for drone logistics networks in urban areas of Switzerland. By 2019, Matternet and UPS launched drone delivery services in the United States, marking the commencement of revenue-generating drone delivery operations in the country. In 2022, the Matternet M2 achieved significant regulatory milestones by obtaining standard Type Certification and Production Certification from the Federal Aviation Administration (FAA). To date, Matternet's technology has facilitated over 20,000 commercial flights, solidifying its position in the drone logistics sector.

Augmedix

Series B in 2019
Augmedix, Inc. is a technology company focused on transforming medical documentation and clinical support through its innovative application. Founded in 2012 and headquartered in San Francisco, California, with additional offices in Menlo Park and Dhaka, the company provides a cloud-based platform that utilizes ambient AI to convert clinician-patient conversations into organized medical notes in real-time. This process significantly reduces the administrative burden on healthcare providers, allowing them to concentrate more on patient care. Augmedix's services are designed for a wide range of healthcare settings, from large hospitals to individual practitioners, enabling seamless integration with electronic health records. The company collaborates with various healthcare organizations to enhance clinical efficiency, operational productivity, and financial performance, charging service fees for its documentation and clinical support services.

IVX Health

Series C in 2019
IVX Health is a prominent provider of infusion and injection therapy, catering to patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics designed to deliver biologic injections and infusions in a private, comfortable, and convenient environment, enhancing the overall patient experience. IVX Health centers, branded as Infusion Express in various cities including Kansas City, Philadelphia, Chicago, and San Francisco, offer flexible scheduling options, including evenings and weekends. Each center features private suites equipped with high-speed Wi-Fi, flat screen TVs, and comfortable recliners, allowing patients to relax during their treatments alongside guests. By focusing on patient comfort and accessibility, IVX Health aims to optimize the infusion care process, making it more effective and cost-efficient for both patients and healthcare providers.

Echo

Acquisition in 2019
Echo, we believe health is about people, not pills. That’s why we’ve created a new kind of pharmacy. One that comes to you, not the other way around. We start with being brilliant at fulfilling prescriptions because getting people taking the right medicine is the first step in staying well. But there’s more we can do. It’s not just patients we support, its partners. Together with other like-minded pharmacies, GPs and prescribing services we deliver even more positive experiences. Ultimately, we want to help patients understand and do more for themselves, so together they can make the right decisions with their GPs. And when it comes time to improve our health, we all know more Technology should make the future of health care more human. So ours comes packed with care.

AllyAlign Health

Corporate Round in 2019
AllyAlign Health, Inc. is a care management company that specializes in supporting patients with chronic and complex medical conditions. Founded in 2013 and headquartered in Glen Allen, Virginia, the company operates an advanced care management platform that facilitates real-time, collaborative care across various healthcare settings. This platform connects patients with care teams and integrates essential health information, care plans, and benefits details, empowering users to make informed care decisions. It offers mobile and web-based access, allowing patients and their families to view, share, create, and update information conveniently from home or from afar. The company's central database is HIPAA compliant and consolidates data from diverse sources, including electronic health records, lab tests, and clinical systems, ensuring comprehensive and meaningful clinical insights through semantic data modeling.

Xealth

Series A in 2019
Xealth Inc. is a digital health company that has developed a comprehensive platform enabling clinicians to integrate, prescribe, and monitor various digital health tools and programs directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, Xealth's platform allows care teams to efficiently order digital health solutions for patients, facilitating seamless communication through email or patient portals. The platform also provides functionality for monitoring patient engagement and analyzing the impact of these tools on patient outcomes. Additionally, Xealth supports non-clinical services, such as ride-sharing and food delivery, enhancing the overall patient experience and promoting greater utilization of digital health resources.

Aetion

Series B in 2019
Aetion, Inc. is a healthcare analytics company that specializes in real-world evidence (RWE) and outcomes-based analytics solutions. Founded in 2012 and based in New York City, Aetion develops the Aetion Evidence Platform, which leverages everyday clinical and financial interactions within the healthcare system to generate critical insights about the effectiveness and value of medical treatments. This platform serves a diverse clientele, including life sciences companies, payers, providers, medical device manufacturers, and academic institutions, allowing them to analyze data from various sources such as claims, electronic health records, registries, and clinical trials. Aetion’s patented rapid-cycle analytics technology facilitates real-time collaboration among stakeholders, enabling them to make informed decisions and optimize patient care. The company has formed strategic partnerships with leading organizations, including McKesson, to enhance its offerings and expand its reach in the healthcare sector.

OncoHealth

Series B in 2018
OncoHealth specializes in oncology benefits management solutions aimed at alleviating the physical, mental, and financial burdens of cancer. The company offers a range of services including prior authorization, clinical decision support, physician education, and expert peer review. Additionally, OncoHealth provides consulting for oncology network evaluation and optimization, as well as performance reporting and analytics. The company also features MATIS, a clinical decision support software that enhances oncology analytics through an evidence-based approach to cancer treatment evaluation and benefits management. Founded in 2009 and headquartered in Atlanta, Georgia, with a secondary location in Plantation, Florida, OncoHealth serves health plans, employers, providers, patients, and life science researchers, leveraging technology and real-world data to navigate the complexities associated with cancer care.

Pharmapacks

Series A in 2018
Pharmapacks is an e-commerce company based in Islandia, New York, specializing in health and beauty products. Established in 2010 as a brick-and-mortar pharmacy, the company has evolved into a comprehensive online marketplace that offers a wide range of items, including multivitamins, nutritional supplements, personal care, and pet care products. Through its proprietary technology platform, Pharmapacks provides logistics, fulfillment, marketing, and sales solutions to brands, enabling them to reach consumers directly via its website and partner platforms such as Amazon, Walmart.com, and eBay. The company also serves as a launchpad for emerging brands, granting select lesser-known products access to its extensive e-commerce infrastructure and consumer base, thereby enhancing their visibility and sales potential.

Propeller Health

Corporate Round in 2018
Propeller Health is a digital health company focused on improving the management of chronic respiratory diseases such as asthma and COPD. The company offers a mobile platform that includes sensors, mobile apps, analytics, and services designed to support respiratory health management. The Propeller sensor attaches to users' inhalers and syncs wirelessly with their smartphones, tracking medication use, triggers, and symptoms. It provides personalized feedback and educational content based on the user's data. Users can set up medication reminders and alerts, and share their data with physicians and family members through the Propeller community. The platform is HIPAA compliant and stores users' data in a secure cloud infrastructure. Propeller Health collaborates with various healthcare organizations and has been recognized with several awards, including the TEDMED Innovation Showcase and White House Champion of Change. The company was founded by David Van Sickle, Greg Tracy, and Mark Gehring and is based in Wisconsin.

Medical Specialties Distributors

Acquisition in 2018
Medical Specialties Distributors, LLC is a full-service distributor of healthcare products primarily serving the home infusion, specialty pharmacy, and oncology markets. Founded in 1984 and based in Stoughton, Massachusetts, the company offers a wide range of products, including infusion pumps, IV supplies, pharmaceuticals, and various medical surgical products. They manufacture several specialized kits and devices, such as dressing change kits and IV administration sets, and provide additional services like biomedical equipment rental, maintenance, and repair. The company also supports clients with equipment management software and online training programs to enhance product utilization and operational efficiency. Medical Specialties Distributors operates a national network of distribution centers and an online ordering platform, with additional locations in Phoenix, Arizona; Bedford, Ohio; Gurnee, Illinois; and St. Louis, Missouri. As of June 2018, it operates as a subsidiary of McKesson Corporation.

Kyruus

Corporate Round in 2018
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.

Accolade

Series F in 2018
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.

RxTPL

Acquisition in 2018
RxTPL is a pharmaceutical company that provides logistic management, graphics, marketing, IT capabilities, and order-to-cash services.

Well.ca

Acquisition in 2017
Well.ca Inc. is an online retailer specializing in health and wellness products, offering a diverse range of items including baby and kids’ essentials, beauty and skincare, personal care, dietary and fitness products, medicines, vitamins, pet supplies, and more. Founded in 2008 and based in Guelph, Canada, Well.ca aims to provide customers with a simple and hassle-free shopping experience. The company caters to consumers across Canada and the continental United States, ensuring easy access to health and beauty products through its online platform. Well.ca operates as a subsidiary of McKesson Canada Corporation, focusing on delivering fast shipping and discounts to enhance the convenience of online shopping for its customers.

RxCrossroads

Acquisition in 2017
RxCrossroads Specialty Solutions focuses on enhancing patient access to therapies through a range of pharmaceutical distribution services. The company offers a comprehensive suite of custom services designed to support both patients and healthcare providers, ensuring that therapies are accessible and effectively utilized. By streamlining the distribution process, RxCrossroads aims to facilitate the commercial success of specialty, generic, and biosimilar drugs within the biotechnology and pharmaceutical industries. Their commitment to individualized support helps distinguish products in a competitive marketplace, ultimately improving patient outcomes.

IVX Health

Series B in 2017
IVX Health is a prominent provider of infusion and injection therapy, catering to patients with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics designed to deliver biologic injections and infusions in a private, comfortable, and convenient environment, enhancing the overall patient experience. IVX Health centers, branded as Infusion Express in various cities including Kansas City, Philadelphia, Chicago, and San Francisco, offer flexible scheduling options, including evenings and weekends. Each center features private suites equipped with high-speed Wi-Fi, flat screen TVs, and comfortable recliners, allowing patients to relax during their treatments alongside guests. By focusing on patient comfort and accessibility, IVX Health aims to optimize the infusion care process, making it more effective and cost-efficient for both patients and healthcare providers.

Truveris

Series D in 2017
Truveris is a health information technology company based in New York that focuses on bringing transparency to the prescription drug ecosystem. Founded in 2009, Truveris develops management tools for sponsors and payers of claims under prescription benefit plans. Its platform offers data-driven insights to help customers, including patients, employers, retailers, pharmacy benefits stakeholders, and manufacturers, manage rising costs and market access challenges effectively. The company's solutions include RxChoice, TruBid, and RxDash, which serve various entities in the pharmacy value chain.

intraFUSION

Acquisition in 2017
intraFUSION, Inc. is a national healthcare management company based in Houston, Texas, specializing in the management of outpatient infusion centers. Founded in 1999, the company serves as a comprehensive provider for physicians, offering a range of services including financial analysis, space planning, employee scheduling, human resources management, billing and reimbursement, inventory control, and regulatory compliance. Additionally, intraFUSION provides software, network, and IT support solutions to enhance operational efficiency. By focusing on office-based infusion services, intraFUSION aims to improve patient care while also generating new revenue streams for medical practices. The company operates as a subsidiary of McKesson Specialty Health, leveraging its extensive expertise in infusion management to support healthcare providers in delivering effective outpatient intravenous therapy.

Carena

Series E in 2017
Carena is a Seattle-based healthcare organization that focuses on enhancing the patient experience through a virtual care model and an adaptable technology platform. The company blends medical expertise with innovative technology and consumer services to offer high-quality healthcare solutions. Its offerings include nurse lines, virtual house calls, wellness programs, and care management services, all designed to provide consumers with on-demand primary care accessible at any time and from any location. By leveraging new care delivery methods, Carena aims to improve patient access to healthcare while generating new referral opportunities for health systems.

Unforgettable.org

Venture Round in 2017
Unforgettable is dedicated to enhancing the lives of individuals impacted by dementia through its extensive online marketplace, which features over 1,000 products designed to assist those with dementia in daily activities. Positioned as the leading destination for dementia-related products and services, Unforgettable not only facilitates the discovery and distribution of these resources but also provides valuable information, expert advice, and a platform for shared experiences. The company is supported by prominent social impact investors, including McKesson Ventures, and is recognized as a B Corp, reflecting its commitment to social good. In collaboration with Lloyds Pharmacy, Unforgettable has expanded its reach by introducing dementia products to physical retail locations, thereby increasing accessibility and raising awareness of the needs of individuals with dementia and their caregivers.

SHYFT Analytics

Series B in 2017
SHYFT Analytics, Inc. is a provider of cloud-based data and analytics solutions tailored for the life sciences industry, both in the United States and internationally. Founded in 2002 and based in Waltham, Massachusetts, the company specializes in integrating clinical and commercial data to deliver patient-centric intelligence and analytics that enhance operational efficiency across research, development, and commercialization processes. Its platform features various solutions, including Sales, Specialty, Launch, Rare Disease, Market Access, and Real World Evidence, which collectively empower life sciences companies to make informed decisions, streamline product launches, and improve patient outcomes. By transforming complex healthcare data into actionable insights, SHYFT Analytics plays a crucial role in supporting the industry's shift towards personalized and value-based medicine. The company has established a strategic partnership with PAREXEL International and operates as a subsidiary of Medidata Solutions, Inc.

CoverMyMeds

Acquisition in 2017
CoverMyMeds, LLC is a company that specializes in electronic prior authorization solutions for healthcare providers. Founded in 2008 and headquartered in Highland Hills, Ohio, with an additional office in Columbus, the company offers a platform that enables electronic health records, payers, pharmacies, and life sciences to complete prior authorization requests efficiently. This process is crucial for insurance companies to approve or deny prescriptions based on formulary status. CoverMyMeds provides a suite of integrated workflow tools designed to simplify the completion of prior authorization and insurance coverage determination forms for physicians and pharmacists at no cost. The company partners with pharmaceutical manufacturers to enhance patient access to branded medications, thereby streamlining the medication approval process and ensuring that patients receive the necessary treatments promptly. In 2017, CoverMyMeds became a subsidiary of McKesson Corporation.

Augmedix

Venture Round in 2016
Augmedix, Inc. is a technology company focused on transforming medical documentation and clinical support through its innovative application. Founded in 2012 and headquartered in San Francisco, California, with additional offices in Menlo Park and Dhaka, the company provides a cloud-based platform that utilizes ambient AI to convert clinician-patient conversations into organized medical notes in real-time. This process significantly reduces the administrative burden on healthcare providers, allowing them to concentrate more on patient care. Augmedix's services are designed for a wide range of healthcare settings, from large hospitals to individual practitioners, enabling seamless integration with electronic health records. The company collaborates with various healthcare organizations to enhance clinical efficiency, operational productivity, and financial performance, charging service fees for its documentation and clinical support services.

SHYFT Analytics

Series B in 2016
SHYFT Analytics, Inc. is a provider of cloud-based data and analytics solutions tailored for the life sciences industry, both in the United States and internationally. Founded in 2002 and based in Waltham, Massachusetts, the company specializes in integrating clinical and commercial data to deliver patient-centric intelligence and analytics that enhance operational efficiency across research, development, and commercialization processes. Its platform features various solutions, including Sales, Specialty, Launch, Rare Disease, Market Access, and Real World Evidence, which collectively empower life sciences companies to make informed decisions, streamline product launches, and improve patient outcomes. By transforming complex healthcare data into actionable insights, SHYFT Analytics plays a crucial role in supporting the industry's shift towards personalized and value-based medicine. The company has established a strategic partnership with PAREXEL International and operates as a subsidiary of Medidata Solutions, Inc.

HealthQx

Acquisition in 2016
HealthQx, established in 2012 and headquartered in King of Prussia, Pennsylvania, specializes in Value-based Payment (VBP) analytic software solutions for health plans and providers. Its flagship product, ClarityQx, empowers users to design, implement, and monitor the performance of alternative payment models such as episodic or bundled arrangements. The platform facilitates provider engagement and contract negotiation processes, aiming to enhance consumer care while reducing medical costs.

RetraceHealth

Series A in 2016
RetraceHealth, Inc. is a healthcare company based in Minneapolis, Minnesota, that provides accessible primary care services through an online platform. Founded in 2013, the company specializes in offering urgent and routine care via video consultations and in-home visits, catering to a range of needs including preventive care, pediatric services, and management of chronic conditions such as high blood pressure and diabetes. RetraceHealth aims to deliver high-quality medical services at affordable prices, essentially offering full-service primary care comparable to traditional clinics but with the convenience of care delivered directly to patients' homes. The platform serves patients primarily in Minnesota and Wisconsin, focusing on enhancing the accessibility and personalization of healthcare.

Evariant

Series C in 2016
Evariant, Inc. is a healthcare technology company that offers a comprehensive platform designed to enhance patient acquisition and retention for healthcare organizations. Founded in 2008 and based in Farmington, Connecticut, Evariant provides a suite of solutions that includes tools for understanding patient demographics, managing marketing campaigns, and fostering engagement with both patients and physicians. Its offerings encompass Patient Market Solver for data analysis, multi-channel CRM solutions for targeted growth, and physician relationship management tools to improve collaboration and recruitment. Additionally, Evariant supports healthcare providers with campaign services, digital media solutions, and professional training. The company aims to deliver actionable insights and improve the effectiveness of marketing strategies, thereby optimizing growth and enhancing the overall patient experience. Evariant serves over 1,000 hospitals nationwide, positioning itself as a trusted partner in the healthcare sector.

Vantage Oncology

Acquisition in 2016
Vantage Oncology, Inc. specializes in providing comprehensive oncology care services, focusing on radiation oncology, medical oncology, and cancer treatment. The company addresses the increasing demand for advanced radiation therapies among cancer patients, hospitals, and physicians. Vantage offers a range of services, including radiation therapy and neurosurgical interventions for various cancer types, such as breast, lung, and prostate cancers. Additionally, Vantage promotes joint venture ownership opportunities, allowing physicians and hospitals to maintain control over their practices while benefiting from the company's extensive network and expertise in radiation oncology. This model not only enhances the capabilities of individual practices but also strengthens the overall quality of cancer care provided to patients.

Rexall

Acquisition in 2016
Rexall Health is an industry-leading healthcare management and technology firm that has been providing customized, value-added health benefit claims management and plan administrative services to Canadian corporations and other health benefit plan sponsors for over 30 years.

Biologics

Acquisition in 2016
Biologics, Inc., established in 1994 and headquartered in Cary, North Carolina, specializes in oncology management services, aiming to optimize cancer care for patients, healthcare providers, payers, and biopharma communities. The company offers a range of services including oncology pharmacy solutions, patient access support, strategic market solutions, and clinical research services. These services encompass advocating for patients, developing drug therapy management plans, facilitating communication, dispensing prescriptions, providing financial assistance, managing clinical trials, and offering customized reporting capabilities. Biologics focuses on integrating fragmented healthcare services to enhance efficiency and patient outcomes in oncology care.

PokitDok

Venture Round in 2016
PokitDok, Inc. is a cloud-based company that provides a comprehensive application programming interface (API) platform designed to facilitate various healthcare transactions. Founded in 2011 and headquartered in San Mateo, California, with an additional office in Charleston, South Carolina, PokitDok enables health systems, technology providers, and developers to enhance their applications by integrating services such as eligibility checks, claims submissions, appointment scheduling, payment processing, and patient identity management. The platform also offers insights on cash costs for health services and includes an e-commerce storefront for practitioners to market their services and allow consumers to pay for treatments upfront. By streamlining workflows and improving operational efficiency, PokitDok supports healthcare organizations in creating patient-centered experiences and modern commerce solutions across the healthcare value chain.

Komodo Health

Series A in 2016
Komodo Health Inc. is a healthcare technology company that develops a platform designed to enhance transparency and intelligence in the healthcare sector. Founded in 2014 and headquartered in New York, with an additional office in San Francisco, the company offers a suite of software applications, including its Healthcare Map, which tracks patient outcomes throughout the healthcare system. Its solutions, such as Aperture and Pulse, leverage advanced data science techniques to provide real-time insights and alerts on clinical information, while Serenity analyzes patient cohorts for deeper understanding. By serving various stakeholders, including life sciences companies, healthcare payers, and providers, Komodo Health aims to foster a more efficient and value-driven healthcare ecosystem through comprehensive patient-level insights.

RetraceHealth

Seed Round in 2016
RetraceHealth, Inc. is a healthcare company based in Minneapolis, Minnesota, that provides accessible primary care services through an online platform. Founded in 2013, the company specializes in offering urgent and routine care via video consultations and in-home visits, catering to a range of needs including preventive care, pediatric services, and management of chronic conditions such as high blood pressure and diabetes. RetraceHealth aims to deliver high-quality medical services at affordable prices, essentially offering full-service primary care comparable to traditional clinics but with the convenience of care delivered directly to patients' homes. The platform serves patients primarily in Minnesota and Wisconsin, focusing on enhancing the accessibility and personalization of healthcare.

PokitDok

Series B in 2015
PokitDok, Inc. is a cloud-based company that provides a comprehensive application programming interface (API) platform designed to facilitate various healthcare transactions. Founded in 2011 and headquartered in San Mateo, California, with an additional office in Charleston, South Carolina, PokitDok enables health systems, technology providers, and developers to enhance their applications by integrating services such as eligibility checks, claims submissions, appointment scheduling, payment processing, and patient identity management. The platform also offers insights on cash costs for health services and includes an e-commerce storefront for practitioners to market their services and allow consumers to pay for treatments upfront. By streamlining workflows and improving operational efficiency, PokitDok supports healthcare organizations in creating patient-centered experiences and modern commerce solutions across the healthcare value chain.

ClearCare

Series C in 2015
ClearCare, Inc. is a technology company that provides a cloud-based platform designed for homecare service agencies, enabling them to manage their operations efficiently. Founded in 2010 and based in San Francisco, ClearCare offers a comprehensive suite of tools that includes scheduling, billing, payroll, customer relationship management, and caregiver training, among others. The platform addresses the needs of various stakeholders in the home care ecosystem, such as caregivers, agency staff, care recipients, and healthcare providers. By integrating these functionalities, ClearCare streamlines processes and enhances service delivery, particularly for seniors who are the primary users of home care services. As a subsidiary of WellSky Corporation since 2019, ClearCare continues to position itself at the forefront of the evolving home healthcare landscape.

Kyruus

Series C in 2015
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.

UDG Healthcare

Acquisition in 2015
UDG Healthcare is a Dublin-based provider of healthcare advisory, communications, commercial, clinical, and packaging services. The company operates through two main divisions: Ashfield and Sharp. Ashfield delivers commercial and medical services, offering advisory, medical, marketing, communications, and patient engagement solutions throughout the lifecycle of a drug. Sharp focuses on packaging services, ensuring that healthcare products are efficiently packaged for market delivery. With a workforce of approximately 8,000 employees across 23 countries, UDG Healthcare specializes in innovative, outsourced solutions that help healthcare companies bring their products to market effectively and efficiently.

Accolade

Series E in 2015
Accolade, Inc. is a technology-driven company that provides personalized health and benefits solutions designed to enhance the healthcare experience for employees and their families in the United States. Founded in 2007 and headquartered in Plymouth Meeting, Pennsylvania, Accolade offers a comprehensive platform that combines cloud-based technology with support from a team of health assistants and clinicians, including nurses and behavioral health specialists. The company's services help employers navigate the complexities of the healthcare system and workplace benefits, ultimately aiming to improve health outcomes and reduce costs. By focusing on healthcare process improvement and employee engagement, Accolade delivers tailored advocacy to meet the specific needs of its clients.

PipelineRx

Venture Round in 2015
PipelineRx is a multi-state organization based in San Francisco, California, focused on telepharmacy and medication management. Founded in 2009 by Brian Roberts, the company develops a cloud-based platform that enhances pharmacy and patient care by utilizing telemedical technology. This platform reviews and verifies medication orders while documenting clinical interventions, allowing hospitals to improve operational efficiencies and clinical outcomes. PipelineRx also emphasizes leadership development and offers online community services tailored for hospital and retail pharmacies.

Carena

Series D in 2015
Carena is a Seattle-based healthcare organization that focuses on enhancing the patient experience through a virtual care model and an adaptable technology platform. The company blends medical expertise with innovative technology and consumer services to offer high-quality healthcare solutions. Its offerings include nurse lines, virtual house calls, wellness programs, and care management services, all designed to provide consumers with on-demand primary care accessible at any time and from any location. By leveraging new care delivery methods, Carena aims to improve patient access to healthcare while generating new referral opportunities for health systems.

Celesio

Acquisition in 2013
Celesio AG is an international trading company that specializes in providing logistics and services in the pharmaceutical and healthcare sector across 16 countries worldwide. The company operates through two divisions: Patient and Consumer Solutions, and Pharmacy Solutions, offering a range of prescription and non-prescription pharmaceuticals. Founded in 1835 by Franz Ludwig Gehe in Dresden, Celesio AG has a long history in the industry and was formerly known as GEHE AG before rebranding in April 2003. With a focus on delivering healthcare solutions to consumers and pharmacies, Celesio AG plays a vital role in the global pharmaceutical supply chain.

PSS World Medical

Acquisition in 2013
An American distributor of medical products, equipment, billing services and pharmaceutical related products

Emendo

Acquisition in 2012
Emendo, founded in 2002 in Christchurch, New Zealand, develops healthcare patient-flow and staffing analytics software, specifically its CapPlan solution. This tool assists over 40 hospitals across New Zealand, Australia, Canada, and the UK in forecasting patient demand and optimizing resource allocation. By leveraging advanced algorithms, CapPlan enhances operational performance and patient care by effectively matching staff and physical resources. Emendo's clients have reported significant operational efficiencies and cost savings, ranging from hundreds of thousands to millions of dollars annually. Notably, the CapPlan implementation at Bedford NHS Trust received recognition in 2009 as the winner of the “Adopt, Adapt and Improve” category at the national Health and Social Care Awards in the UK.

MED3000

Acquisition in 2012
MED3000 is a healthcare management company based in Pittsburgh, Pennsylvania, established in 1995. The firm specializes in developing technology solutions and services aimed at enhancing healthcare operations. Its product offerings include billing and revenue cycle management, electronic health records, practice management, coding and compliance services, and patient outreach initiatives. MED3000 also provides solutions for EMS billing and third-party administration, along with a data warehouse for improved information management. In October 2012, the company was acquired by McKesson, strengthening its position in the healthcare technology sector.

MedVentive

Acquisition in 2012
MedVentive is a technology solutions provider specializing in healthcare delivery systems, payers, and employer coalitions. Founded in 1997 by physicians, the company focuses on developing innovative solutions aimed at enhancing the quality of care while reducing associated costs. MedVentive's offerings include quality management, clinical integration, pharmacy management, and point-of-care decision support. Additionally, the company provides a pay-for-performance solution that calculates and tracks clinical measures, delivering tailored patient intervention recommendations. Through these services, MedVentive enables physician groups and integrated delivery systems to implement meaningful changes in their healthcare practices.

peerVue

Acquisition in 2012
Since its inception in 2002, peerVue has been redefining the healthcare IT market with intelligent workflow and communication solutions that enable healthcare organizations to improve patient care, while also reducing risk and simplifying processes. With a passion for technology and innovation, peerVue was established to solve critical workflow and communication gaps in healthcare that jeopardize patient safety and render imaging organizations inefficient. peerVue delivers solutions worldwide with dozens of integrations to leading healthcare imaging and IT across multiple specialties, including radiology, mammography, cardiology and pathology.

Drug Trading

Acquisition in 2012
Drug Trading Company Limited, a subsidiary of Katz Group Canada Inc., operates as an independent banner business, managing Medicine Shoppe Canada Inc., a franchise network. The company specializes in providing pharmacy banner programs and services, including flyer programs, holiday gift books, and advertising initiatives, serving independent and franchise pharmacies across Canada.

Portico Systems

Acquisition in 2011
Portico Systems is a provider of software applications designed for healthcare organizations, focusing on the management of complex provider networks. The company's technology enables these organizations to design, build, and service their networks effectively, facilitating value-based reimbursement. Portico Systems automates essential network management activities, including provider enrollment, credentialing, contracting, and pricing. By transforming the performance management of provider networks, the company helps to significantly reduce medical, administrative, and information technology costs for health plans.

US Oncology

Acquisition in 2010
US Oncology is a leading organization in the field of cancer care, operating one of the largest networks of integrated, community-based oncology practices in the United States. The organization is physician-led and focuses on enhancing patient outcomes and quality of life through a commitment to evidence-based cancer care. It provides a wide range of services, including medical oncology, cancer center operations, and cancer research. Additionally, US Oncology offers pharmaceutical services such as inventory management and drug preparation, as well as practice management services encompassing billing, financial planning, and information technology support. By leveraging healthcare information technology and shared best practices, US Oncology aims to improve access to high-quality cancer care within local communities, collaborating with various payers, hospitals, and academic institutions to strengthen its impact on patient care.

EN-Chart Scanning Program

Acquisition in 2008
A provider of computer-assisted facility coding and compliance solutions for emergency department visits.

McQueary Brothers

Acquisition in 2008
McQueary Bros. Drug Company, a Springfield, Missouri–based regional distributor of pharmaceutical, health, and beauty products to more than 400 independent pharmacies in Missouri, Arkansas, Illinois, Kansas, Oklahoma, Nebraska, and Iowa.

Vivalog Technologies

Acquisition in 2008
Vivalog Technologies specializes in developing knowledge management software solutions tailored for hospitals and research institutions. The company offers a range of products, including image management systems for clinical trials and investigator-initiated research projects. Additionally, Vivalog provides enterprise knowledge management tools that support decision-making and training processes. Its offerings also include radiology and pathology teaching files, alongside comprehensive content management services, aimed at enhancing the operational efficiency and educational capabilities of healthcare organizations.

Rosebud Solutions

Acquisition in 2008
Rosebud Solutions, LLC designs, develops, markets, and supports a suite of workflow process improvement software programs.

Oncology Therapeutics Network

Acquisition in 2007
Oncology Therapeutics Network is a physician services company. It provides technology solutions, distribution services, practice management tools, and educational programs. The company offers brand and generic pharmaceuticals; Lynx Technology Platform, a charge capture and inventory management and reporting tool; Lynx EMR, a functional subscription-based electronic medical record software service; financial solutions; Web-based portal that manages various clinics' critical processes; and home delivery services for self-administered medications, as well as manages benefits investigation and insurance claims. Oncology Therapeutics Network was founded in 1990 and is headquartered in San Francisco, California.

Awarix

Acquisition in 2007
Awarix develops software and online tools tailored for the healthcare industry. Based in Alabama, USA, the company offers a digital platform designed to manage all patient data efficiently. Awarix provides communication and reporting tools that enable operational and administrative staff to quickly access critical information across the entire healthcare enterprise.

Practice Partner

Acquisition in 2007
Practice Partner, Inc. provides electronic health record and practice management solutions.

Per-Se Technologies

Acquisition in 2007
Per-Se Technologies is a provider of healthcare business and information technology services that focuses on enhancing the financial performance of physicians, hospitals, and retail pharmacies. The company's solutions are designed to streamline reimbursement processes, allowing healthcare providers to receive payments more quickly. By optimizing revenue cycles and providing essential tools, Per-Se Technologies enables healthcare organizations to concentrate on delivering quality patient care while maximizing their income potential.

RelayHealth

Acquisition in 2006
RelayHealth is a provider of online healthcare communication services that facilitates secure and convenient information exchange among various healthcare stakeholders, including patients, providers, pharmacies, payors, and pharmaceutical manufacturers. The company offers a range of services such as ePrescribing, online refills, access to lab results, reimbursable online visits, and online bill payments. By enabling consistent connectivity among medical companies, doctors, and patients, RelayHealth aims to streamline interactions within the healthcare system. This connectivity ultimately contributes to improved patient care, faster access to necessary services, reduced costs, and enhanced operational efficiency for healthcare providers.

HealthCom Partners

Acquisition in 2006
A leading provider of patient billing solutions.

Sterling Medical Services

Acquisition in 2006
Founded in 1992, Sterling Medical Services, LLC is a national provider and distributor of medical disposable supplies and health management services to the homecare market. Our customers include managed care organizations and other health insurance plans, home health nursing agencies, physician practices, rehab facilities, out-patient clinics, hospital discharge nursing, and individual patients.

NDCHealth

Acquisition in 2006
NDC Health provides healthcare information solutions. Its products and services comprise point-of-care systems, electronic prescription connections, patient scheduling, claims processing, billing, and other financial management. The company’s solutions address various administrative, clinical, and operational informational needs. It serves physicians, hospitals, pharmaceutical manufacturers, retail pharmacies, and managed care organizations.

D & K Healthcare Resources

Acquisition in 2005
D&K Healthcare Resources, Inc. operates as a wholesale drug distributor in the United States.

Medcon

Acquisition in 2005
Medcon is a global leader in cardiac image and information management solutions, focused on enhancing the quality and cost-effectiveness of healthcare. The company provides web-based products specifically designed for heart centers, including diagnostic digital image management, archiving, procedure reporting, and workflow management. These solutions facilitate rapid access to complete and accurate images and information over both local and remote networks, enabling cardiologists to deliver optimal care to patients. Medcon's software applications are developed using advanced technology and adhere to industry standards, with over 300 installations worldwide, underscoring its commitment to improving cardiac treatment and patient outcomes.

Moore Medical

Acquisition in 2004
Moore Medical is a marketer and distributor of medical, surgical, and pharmaceutical products tailored for non-hospital healthcare providers. Over its 55-year history, the company has built a robust customer base that includes nearly 100,000 healthcare practices and facilities, such as physicians, emergency medical technicians, schools, correctional institutions, municipalities, and occupational health professionals. Moore Medical employs a multi-channel approach to reach its customers, utilizing direct mail, specialized telephone support, field sales representatives, customer community affiliates, and online platforms to effectively serve diverse specialty practice communities.

A.L.I. Technologies

Acquisition in 2002
A.L.I. provides medical imaging solutions which are designed to streamline access to diagnostic information, automate clinical workflow and eliminate the need for film.

MediVation

Acquisition in 2000
MediVation’s electronic provider-patient interface, which enables providers to transfer data to secure patient Web pages, into its clinical and administrative applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.